Nucleic acid aptamers: New methods for selection, stabilization, and application in biomedical science

Biomolecules and Therapeutics

Volumn 21, Issue 6, 2013, Pages 423-434

  Kong, Hoon Young ^a   Byun, Jonghoe ^a  

^a Dankook University   (South Korea)

Author keywords

Aptamer; Drug delivery system; Imaging; Modification; SELEX; Stabilization

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; APTAMER; CD137 ANTIGEN; DOXORUBICIN; GOLD NANOPARTICLE; MEMBRANE ANTIGEN; PEGAPTANIB; PHOTOSENSITIZING AGENT; SMALL INTERFERING RNA; THROMBIN; TOXIN; VASCULOTROPIN; VIRUS PROTEIN;

AGONIST; BINDING AFFINITY; CAPILLARY ELECTROPHORESIS; CELL DEATH; CELLS; CHEMICAL MODIFICATION; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; HUMAN; IMAGING; IMMUNOGENICITY; IN VITRO SELECTION; MICROFLUIDICS; MOLECULAR IMAGING; NON EQUILIBRIUM CAPILLARY ELECTROPHORESIS OF EQUILIBRIUM MIXTURE; NONHUMAN; PROTEIN DNA BINDING; REVIEW; THERMOSTABILITY;

EID: 84888789869     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2013.085     Document Type: Review

References (118)

1. Andreola, M. L., Calmels, C., Michel, J., Toulmé, J. J. and Litvak, S. (2000) Towards the selection of phosphorothioate aptamers:optimizing in vitro selection steps with phosphorothioate nucleotides. Eur. J. Bio-chem. 267, 5032-5040.
2. Aravind, A., Jeyamohan, P., Nair, R., Veeranarayanan, S., Nagaoka, Y., Yoshida, Y., Maekawa, T. and Kumar, D. S. (2012) AS1411 ap-tamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery. Biotechnol. Bioeng. 109, 2920-2931.
3. Bagalkot, V., Farokhzad, O. C., Langer, R. and Jon, S. (2006) An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew. Chem. Int. Ed. Engl. 45, 8149-8152.
4. Banaszynski, M. and Kolesar, J. M. (2013) Vemurafenib and ipilim-umab: New agents for metastatic melanoma. Am. J. Health Syst. Pharm. 70, 1205-1210.
5. Barciszewski, J., Medgaard, M., Koch, T., Kurreck, J. and Ermann, V. A. (2009) Locked nucleic acid aptamers. Methods Mol. Biol. 535, 165-186.
6. Berezovski, M., Drabovich, A., Krylova, S. M., Musheev, M., Okhonin, V., Petrov, A. and Krylov, S. N. (2005) Nonequilibrium capillary electrophoresis of equilibrium mixtures: a universal tool for development of aptamers. J. Am. Chem. Soc. 127, 3165-3171.
7. Berezovski, M., Musheev, M., Drabovich, A. and Krylov, S. N. (2006) Non-SELEX selection of aptamers. J. Am. Chem. Soc. 128, 1410-1411.
8. Blank, M., Weinschenk, T., Priemer, M. and Schluesener, H. (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 276, 16464-16468.
9. Bruno, J. G., Carrillo, M. P., Phillips, T., Vail, N. K. and Hanson, D. (2008) Competitive FRET-aptamer-based detection of methylphos- phonic acid, a common nerve agent metabolite. J. Fluoresc. 18, 867-876.
10. Cai, W. and Chen, X. (2007) Nanoplatforms for targeted molecular imaging in living subjects. Small 3, 1840-1854.
11. Chen, F., Hu, Y., Li, D., Chen, H. and Zhang, X. L. (2009) CS-SELEX generates high-affi nity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2. PLoS One 4, e8142
12. Chu, T. C., Marks, J. W. 3rd, Lavery, L. A., Faulkner, S., Rosenblum, M. G., Ellington, A. D. and Levy, M. (2006a) Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res. 66, 5989-5992.
13. Chu, T. C., Twu, K. Y., Ellington, A. D. and Levy, M. (2006b) Aptamer mediated siRNA delivery. Nucleic Acids Res. 34, e73
14. Cox, J. C., Rudolph, P. and Ellington, A. D. (1998) Automated RNA selection. Biotechnol. Prog. 14, 845-850.
15. Cui, Z. Q., Ren, Q., Wei, H. P., Chen, Z., Deng, J. Y., Zhang, Z. P. and Zhang, X. E. (2011) Quantum dot-aptamer nanoprobes for recognizing and labeling infl uenza A virus particles. Nanoscale. 3, 2454-2457.
16. Diener, J. L., Daniel Lagassé, H. A., Duerschmied, D., Merhi, Y., Tan-guay, J. F., Hutabarat, R., Gilbert, J., Wagner, D. D. and Schaub, R. (2009) Inhibition of von Willebrand factor-mediated platelet activation and thrombosis by the anti-von Willebrand factor A1-domain aptamer ARC1779. J. Thromb. Haemost. 7, 1155-1162.
17. Dollins, C. M., Nair, S., Boczkowski, D., Lee, J., Layzer, J. M., Gilboa, E. and Sullenger, B. A. (2008) Assembling OX40 aptamers on a molecular scaffold to create a receptor-activating aptamer. Chem. Biol. 15, 675-682.
18. Ellington, A. D. and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822.
19. Eyetech Study Group. (2002) Preclinical and phase 1A clinical evaluation of an anti-vegf pegylated aptamer (Eye001) for the treatment of exudative age-related macular degeneration. Retina. 22, 143-152.
20. Floege, J., Ostendorf, T., Janssen, U., Burg, M., Radeke, H. H., Varg-eese, C., Gill, S. C., Green, L. S. and Janjić, N. (1999) Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am. J. Pathol. 154, 169-179.
21. Foy, J. W., Rittenhouse, K., Modi, M. and Patel, M. (2007) Local tolerance and systemic safety of pegaptanib sodium in the dog and rabbit. J. Ocul. Pharmacol. Ther. 23, 452-466.
22. Gilboa, E., McNamara, J. 2nd and Pastor, F. (2013) Use of oligonucle-otide aptamer ligands to modulate the function of immune receptors. Clin. Cancer Res. 19, 1054-1062.
23. Gissel, M., Orfeo, T., Foley, J. H. and Butenas, S. (2012) Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. Thromb. Res. 130, 948-955.
24. Gudima, S.O., Kostyuk, D. A., Grishchenko, O. I., Tunitskaya, V. L., Memelova, L. V. and Kochetkov, S. N. (1998) Synthesis of mixed ribo/deoxyribopolynucleotides by mutant T7 RNA polymerase. FEBS Lett. 439, 302-306.
25. Hamula, C. L., Le, X. C. and Li, X. F. (2011) DNA aptamers binding to multiple prevalent M-types of Streptococcus pyogenes. Anal. Chem. 83, 3640-3647.
26. Han, D., Zhu, G., Wu, C., Zhu, Z., Chen, T., Zhang, X. and Tan, W. (2013) Engineering a cell-surface aptamer circuit for targeted and amplifi ed photodynamic cancer therapy. ACS Nano 7, 2312-2319.
27. Healy, J. M., Lewis, S. D., Kurz, M., Boomer, R. M., Thompson, K. M., Wilson, C. and McCauley, T. G. (2004) Pharmacokinetics and biodistribution of novel aptamer compositions. Pharm. Res. 21, 2234-2246.
28. Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S. and Schmidt, P. G. (2006) Tumor targeting by an aptamer. J. Nucl. Med. 47, 668-678.
29. Holahan, M. R., Madularu, D., McConnell, E. M., Walsh, R. and DeRosa, M. C. (2011) Intra-accumbens injection of a dopamine aptamer abates MK-801-induced cognitive dysfunction in a model of schizophrenia. PLoS One 6, e22239.
30. Holland, C. A., Henry, A. T., Whinna, H. C. and Church, F. C. (2000) Effect of oligodeoxynucleotide thrombin aptamer on thrombin inhibition by heparin cofactor II and antithrombin. FEBS Lett. 484, 87-91.
31. Hong, H., Goel, S., Zhang, Y. and Cai, W. (2011) Molecular imaging with nucleic acid aptamers. Curr. Med. Chem. 18, 4195-4205.
32. Hooks, M. A., Wade, C. S. and Millikan, W. J. (1991) Muromonab CD-3: a review of its pharmacology, pharmacokinetics, and clinical use in transplantation. Pharmacotherapy 11, 26-37.
33. Horhota, A., Zou, K., Ichida, J. K., Yu, B., McLaughlin, L. W., Szostak, J. W. and Chaput, J. C. (2005) Kinetic analysis of an efficient DNA-dependent TNA polymerase. J. Am. Chem. Soc. 127, 7427-7434.
34. Huang, Y. F., Shangguan, D., Liu, H., Phillips, J. A., Zhang, X., Chen, Y. and Tan, W. (2009) Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. Chembiochem. 10, 862-868.
35. Hussain, A. F., Tur, M. K. and Barth, S. (2013) An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin. Nucleic Acid Ther. 23, 203-212.
36. Hwang do, W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S. and Kim, S. (2010) A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an ap-tamer. J. Nucl. Med. 51, 98-105.
37. Hybarger, G., Bynum, J., Williams, R. F., Valdes, J. J. and Chambers, J. P. (2006) A microfl uidic SELEX prototype. Anal. Bioanal. Chem. 384, 191-198.
38. Ichida, J. K., Zou, K., Horhota, A., Yu, B., McLaughlin, L. W. and Szostak, J. W. (2005) An in vitro selection system for TNA. J. Am. Chem. Soc. 127, 2802-2803.
39. Jayasena, S. D. (1999) Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 45, 1628-1650.
40. Jenison, R. D., Gill, S. C., Pardi, A. and Polisky, B. (1994) High-resolution molecular discrimination by RNA. Science 263, 1425-1429.
41. Kasahara, Y. and Kuwahara, M. (2012) Artificial specific binders directly recovered from chemically modified nucleic Acid libraries. J. Nucleic Acids 2012, 156482.
42. Kasahara, Y., Irisawa, Y., Ozaki, H., Obika, S. and Kuwahara, M. (2013) 2',4'-BNA/LNA aptamers: CE-SELEX using a DNA-based library of full-length 2'-O, 4'-C-methylene-bridged/linked bicyclic ri-bonucleotides. Bioorg. Med. Chem. Lett. 23, 1288-1292.
43. 2+. J. Inorg. Biochem. 82, 197-206.
44. Kempeneers, V., Renders, M., Froeyen, M. and Herdewijn, P. (2005) Investigation of the DNA-dependent cyclohexenyl nucleic acid polymerization and the cyclohexenyl nucleic acid-dependent DNA polymerization. Nucleic Acids Res. 33, 3828-3836.
45. Kim, D., Jeong, Y. Y. and Jon, S. (2010) A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 4, 3689-3696.
46. Kim, S., Kim, Y., Kim, P., Ha, J., Kim, K., Sohn, M., Yoo, J. S., Lee, J., Kwon, J. A. and Lee, K. N. (2006) Improved sensitivity and physical properties of sol-gel protein chips using large-scale material screening and selection. Anal. Chem. 78, 7392-7396.
47. Klussmann, S., Nolte, A., Bald, R., Erdmann, V. A. and Fürste, J. P. (1996) Mirror-image RNA that binds D-adenosine. Nat. Biotechnol. 14, 1112-1115.
48. Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J. and Daddona, P. (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Mol. Immunol. 30, 1443-1453.
49. Kolesnikova, O., Kazakova, H., Comte, C., Steinberg, S., Kamenski, P., Martin, R. P., Tarassov, I. and Entelis, N. (2010) Selection of RNA aptamers imported into yeast and human mitochondria. RNA 16, 926-941.
50. Kuwahara, M., Obika, S., Nagashima, J., Ohta, Y., Suto, Y., Ozaki, H., Sawai, H. and Imanishi, T. (2008) Systematic analysis of enzymatic DNA polymerization using oligo-DNA templates and triphosphate analogs involving 2',4'-bridged nucleosides. Nucleic Acids Res. 36, 4257-4265.
51. Kuwahara, M., Takahata, Y., Shoji, A., Ozaki, A. N., Ozaki, H. and Sawai, H. (2003) Substrate properties of C5-substituted pyrimidine 2'-deoxynucleoside 5'-triphosphates for thermostable DNA poly-merases during PCR. Bioorg. Med. Chem. Lett. 13, 3735-3738.
52. Kuwahara, M., Takano, Y., Kasahara, Y., Nara, H., Ozaki, H., Sawai, H., Sugiyama, A. and Obika, S. (2010) Study on suitability of KOD dna polymerase for enzymatic production of artificial nucleic acids using base/sugar modified nucleoside triphosphates. Molecules 15, 8229-8240.
53. Kuwahara, M., Takeshima, H., Nagashima, J., Minezaki, S., Ozaki, H. and Sawai, H. (2009) Transcription and reverse transcription of ar-tificial nucleic acids involving backbone modification by template directed DNA polymerase reactions. Bioorg. Med. Chem. 17, 3782-3788.
54. Latham, J. A., Johnson, R. and Toole, J. J. (1994) The application of a modified nucleotide in aptamer selection: novel thrombin aptamers containing 5-(1-pentynyl)-2'-deoxyuridine. Nucleic Acids Res. 22, 2817-2822.
55. Lato, S. M., Ozerova, N. D., He, K., Sergueeva, Z., Shaw, B. R. and Burke, D. H. (2002) Boron-containing aptamers to ATP. Nucleic Acids Res. 30, 1401-1407.
56. Lauhon, C. T. and Szostak, J. W. (1995) RNA aptamers that bind fl avin and nicotinamide redox cofactors. J. Am. Chem. Soc. 117, 1246-1257.
57. Leal, N. A., Sukeda, M. and Benner, S. A. (2006) Dynamic assembly of primers on nucleic acid templates. Nucleic Acids Res. 34, 4702-4710.
58. Leva, S., Lichte, A., Burmeister, J., Muhn, P., Jahnke, B., Fesser, D., Erfurth, J., Burgstaller, P. and Klussmann, S. (2002) GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism. Chem. Biol. 9, 351-359.
59. Li, F., Du, Z., Yang, L. and Tang, B. (2013) Selective and sensitive turn-on detection of adenosine triphosphate and thrombin based on bi-functional fluorescent oligonucleotide probe. Biosens. Bioelectron. 41, 907-910.
60. Li, M., Lin, N., Huang, Z., Du, L., Altier, C., Fang, H. and Wang, B. (2008) Selecting aptamers for a glycoprotein through the incorporation of the boronic acid moiety. J. Am. Chem. Soc. 130, 12636-12638.
61. Liu, Z., Duan, J. H., Song, Y. M., Ma, J., Wang, F. D., Lu, X., Yang X. D. (2012) Novel HER2 aptamer selectively delivers cyto-toxic drug to HER2-positive breast cancer cells in vitro. J. Transl. Med. 10, 148.
62. Lou, X., Qian, J., Xiao, Y., Viel, L., Gerdon, A. E., Lagally, E. T., Atz-berger, P., Tarasow, T. M., Heeger, A. J. and Soh, H. T. (2009) Mi-cromagnetic selection of aptamers in microfl uidic channels. Proc. Natl. Acad. Sci. U.S.A 106, 2989-2994.
63. Mann, A. P., Bhavane, R. C., Somasunderam, A., Liz Montalvo-Ortiz, B., Ghaghada, K. B., Volk, D., Nieves-Alicea, R., Suh, K. S., Ferrari, M., Annapragada, A., Gorenstein, D. G. and Tanaka, T. (2011) Thioaptamer conjugated liposomes for tumor vasculature targeting. Oncotarget 2, 298-304.
64. Mann, D., Reinemann, C., Stoltenburg, R. and Strehlitz, B. (2005) In vitro selection of DNA aptamers binding ethanolamine. Biochem. Biophys. Res. Commun. 338, 1928-1934.
65. Maul, T. M., Dudgeon, D. D., Beste, M. T., Hammer, D. A., Lazo, J. S., Villanueva, F. S. and Wagner, W. R. (2010) Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strength. Biotechnol. Bioeng. 107, 854-864.
66. Mazumdar, S. and Greenwald, D. (2009) Golimumab. MAbs 1, 422-431.
67. McIntyre, J. O. and Matrisian, L. M. (2003) Molecular imaging of pro-teolytic activity in cancer. J. Cell. Biochem. 90, 1087-1097.
68. McNamara, J. O. 2nd, Andrechek, E. R., Wang, Y., Viles, K. D., Rem-pel, R. E., Gilboa, E., Sullenger, B. A. and Giangrande, P. H. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 24, 1005-1015.
69. McNamara, J. O., Kolonias, D., Pastor, F., Mittler, R. S., Chen, L., Giangrande, P. H., Sullenger, B. and Gilboa, E. (2008) Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J. Clin. Invest. 118, 376-386.
70. Meng, L., Yang, L., Zhao, X., Zhang, L., Zhu, H., Liu, C. and Tan, W. (2012) Targeted delivery of chemotherapy agents using a liver can-cer-specific aptamer. PLoS One 7, e33434.
71. Mi, J., Liu, Y., Rabbani, Z. N., Yang, Z., Urban, J. H., Sullenger, B. A. and Clary, B. M. (2010) In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 6, 22-24.
72. Mosing, R. K., Mendonsa, S. D. and Bowser, M. T. (2005) Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Anal. Chem. 77, 6107-6112.
73. Neff, C. P., Zhou, J., Remling, L., Kuruvilla, J., Zhang, J., Li, H., Smith, D. D., Swiderski, P., Rossi, J. J. and Akkina, R. (2011) An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice. Sci. Transl. Med. 3, 66ra6.
74. Nitsche, A., Kurth, A., Dunkhorst, A., Pänke, O., Sielaff, H., Junge, W., Muth, D., Scheller, F., Stöcklein, W., Dahmen, C., Pauli, G. and Kage, A. (2007) One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX. BMC Biotechnol. 7, 48.
75. Nolte, A., Klussmann, S., Bald, R., Erdmann, V. A. and Furste, J. P. (1996) Mirror-design of L-oligonucleotide ligands binding to L-argi-nine. Nat. Biotechnol. 14, 1116-1119.
76. Pageau, S. C. (2009) Denosumab. MAbs 1, 210-215.
77. Park, S. M., Ahn, J. Y., Jo, M., Lee, D. K., Lis, J. T., Craighead, H. G. and Kim, S. (2009) Selection and elution of aptamers using nano-porous sol-gel arrays with integrated microheaters. Lab Chip 9, 1206-1212.
78. Pastor, F., Soldevilla, M. M., Villanueva, H., Kolonias, D., Inoges, S., de Cerio, A. L., Kandzia, R., Klimyuk, V., Gleba, Y., Gilboa, E. and Bendandi, M. (2013) CD28 aptamers as powerful immune response modulators. Mol. Ther. Nucleic Acids 2, e98.
79. Rockey, W. M., Huang, L., Kloepping, K. C., Baumhover, N. J., Giangrande, P. H. and Schultz, M. K. (2011) Synthesis and radio-labeling of chelator-RNA aptamer bioconjugates with copper-64 for targeted molecular imaging. Bioorg. Med. Chem. 19, 4080-4090.
80. Römer, P. S., Berr, S., Avota, E., Na, S. Y., Battaglia, M., ten Berge, I., Einsele, H. and Hünig, T. (2011) Preculture of PBMCs at high cell density increases sensitivity of T-cell responses, revealing cytokine release by CD28 superagonist TGN1412. Blood 118, 6772-6782.
81. Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Hen-ninger, D. D., Claesson-Welsh, L. and Janjić, N. (1998) 2'-Fluo-ropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J. Biol. Chem. 273, 20556-20567.
82. Savla, R., Taratula, O., Garbuzenko, O. and Minko, T. (2011) Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer. J. Control. Release 153, 16-22.
83. Schmidt, K. S., Borkowski, S., Kurreck, J., Stephens, A. W., Bald, R., Hecht, M., Friebe, M., Dinkelborg, L. and Erdmann, V. A. (2004) Application of locked nucleic acids to improve aptamer in vivo stability and targeting function. Nucleic Acids Res. 32, 5757-5765.
84. Schneider, D. J., Feigon, J., Hostomsky, Z. and Gold, L. (1995) High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 34, 9599-9610.
85. Shi, H., Tang, Z., Kim, Y., Nie, H., Huang, Y. F., He, X., Deng, K., Wang, K. and Tan, W. (2010) In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX. Chem. Asian J. 5, 2209-2213.
86. Shoji, A., Kuwahara, M., Ozaki, H. and Sawai, H. (2007) Modified DNA aptamer that binds the (R)-isomer of a thalidomide derivative with high enantioselectivity. J. Am. Chem. Soc. 129, 1456-1464.
87. Siller-Matula, J. M., Merhi, Y., Tanguay, J. F., Duerschmied, D., Wagner, D. D., McGinness, K. E., Pendergrast, P. S., Chung, J. K., Tian, X., Schaub, R. G. and Jilma, B. (2012) ARC15105 is a potent antagonist of von Willebrand factor mediated platelet activation and adhesion. Arterioscler. Thromb. Vasc. Biol. 32, 902-909.
88. Song, Y., Zhu, Z., An, Y., Zhang, W., Zhang, H., Liu, D., Yu, C., Duan, W. and Yang, C. J. (2013) Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture. Anal. Chem. 85, 4141-4149.
89. Subramanian, N., Raghunathan, V., Kanwar, J. R., Kanwar, R. K., El-churi, S. V., Khetan, V. and Krishnakumar, S. (2012) Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol. Vis. 18, 2783-2795.
90. Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cor-tes, A., Brunner, M. D. and Panoskaltsis, N. (2006) Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N. Engl. J. Med. 355, 1018-1028.
91. Talbot, L. J., Mi, Z., Bhattacharya, S. D., Kim, V., Guo, H. and Kuo, P. C. (2011) Pharmacokinetic characterization of an RNA aptamer against osteopontin and demonstration of in vivo efficacy in reversing growth of human breast cancer cells. Surgery 150, 224-230.
92. Tang, Z., Parekh, P., Turner, P., Moyer, R. W. and Tan, W. (2009) Generating aptamers for recognition of virus-infected cells. Clin. Chem. 55, 813-822.
93. Tsai, C. H., Chen, J. and Szostak, J. W. (2007) Enzymatic synthesis of DNA on glycerol nucleic acid templates without stable duplex formation between product and template. Proc. Natl. Acad. Sci. USA 104, 14598-14603.
94. Tsien, R. Y. (2005) Building and breeding molecules to spy on cells and tumors. FEBS Lett. 579, 927-932.
95. Tuerk, C. and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA poly-merase. Science 249, 505-510.
96. Vater, A., Sell, S., Kaczmarek, P., Maasch, C., Buchner, K., Pruszyns-ka-Oszmalek, E., Kolodziejski, P., Purschke, W. G., Nowak, K. W., Strowski, M. Z. and Klussmann, S. (2013) A mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes. J. Biol. Chem. 288, 21136-21147.
97. Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K. and Eaton, B. E. (2010) Expanding the chemistry of DNA for in vitro selection. J. Am. Chem. Soc. 132, 4141-4151.
98. Veedu, R. N., Vester, B. and Wengel, J. (2009) Efficient enzymatic synthesis of LNA-modifi ed DNA duplexes using KOD DNA poly-merase. Org. Biomol. Chem. 7, 1404-1409.
99. Wang, C. H., Huang, Y. F. and Yeh, C. K. (2011) Aptamer-conjugated nanobubbles for targeted ultrasound molecular imaging. Langmuir 27, 6971-6976.
100. Wang, J., Jiang, H. and Liu, F. (2000) In vitro selection of novel RNA ligands that bind human cytomegalovirus and block viral infection. RNA 6, 571-583.
101. White, R., Rusconi, C., Scardino, E., Wolberg, A., Lawson, J., Hoffman, M. and Sullenger, B. (2001) Generation of species cross-reactive aptamers using toggle SELEX. Mol. Ther. 4, 567-573.
102. Williams, K. P., Liu, X. H., Schumacher, T. N., Lin, H. Y., Ausiello, D. A., Kim, P. S. and Bartel, D. P. (1997) Bioactive and nuclease-re-sistant L-DNA ligand of vasopressin. Proc. Natl. Acad. Sci. U.S.A. 94, 11285-11290.
103. Wittung, P., Nielsen, P. E., Buchardt, O., Egholm, M. and Nordén, B. (1994) DNA-like double helix formed by peptide nucleic acid. Nature 368, 561-563.
104. Wullner, U., Neef, I., Eller, A., Kleines, M., Tur, M. K. and Barth, S. (2008) Cell-specific induction of apoptosis by rationally designed bivalent aptamer-siRNA transcripts silencing eukaryotic elongation factor 2. Curr. Cancer Drug Targets 8, 554-565.
105. Xu, W. and Lu, Y. (2011) A smart magnetic resonance imaging contrast agent responsive to adenosine based on a DNA aptamer-conjugat-ed gadolinium complex. Chem. Commun. 47, 4998-5000.
106. Yang, X., Fennewald, S., Luxon, B. A., Aronson, J., Herzog, N. K. and Gorenstein, D. G. (1999) Aptamers containing thymidine 3'-O-phosphorodithioates: synthesis and binding to nuclear factor-κB. Bioorg. Med. Chem. Lett. 9, 3357-3362.
107. Yang, X., Huang, J., Wang, K., Li, W., Cui, L. and Li, X. (2011) An-giogenin-mediated photosensitizer-aptamer conjugate for photody-namic therapy. ChemMedChem 6, 1788-1780.
108. Yigit, M. V., Mazumdar, D., Kim, H. K., Lee, J. H., Odintsov, B. and Lu, Y. (2007) Smart turn-on magnetic resonance contrast agents based on aptamer-functionalized superparamagnetic iron oxide nanoparticles. Chembiochem 8, 1675-1678.
109. 2+ quantum dots for tumor-targeted fluorescence imaging in vitro and in vivo. Anal. Chem. 85, 5843-5849.
110. Zhang, M. Z., Yu, R. N., Chen, J., Ma, Z. Y. and Zhao, Y. D. (2012) Targeted quantum dots fluorescence probes functionalized with aptamer and peptide for transferrin receptor on tumor cells. Nano-technology 23, 485104.
111. Zhang, Y., Hong, H. and Cai W. (2011) Tumor-targeted drug delivery with aptamers. Curr. Med. Chem. 18, 4185-4194.
112. Zhou, B. and Wang, B. (2006) Pegaptanib for the treatment of age-related macular degeneration. Exp. Eye Res. 83, 615-619.
113. Zhou, J., Li, H., Li, S., Zaia, J. and Rossi, J. J. (2008) Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol. Ther. 16, 1481-1489.
114. Zhou, J., Li, H., Zhang, J., Piotr, S. and Rossi J. (2011a) Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery. J. Vis. Exp. 23, 2954.
115. Zhou, J., Neff, C. P., Swiderski, P., Li, H., Smith, D. D., Aboellail, T., Remling-Mulder, L., Akkina, R. and Rossi, J. J. (2013) Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge. Mol. Ther. 21, 192-200.
116. Zhou, J., Shu, Y., Guo, P., Smith, D. D. and Rossi, J. J. (2011b) Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. Methods 54, 284-294.
117. Zhu, G., Ye, M., Donovan, M. J., Song, E., Zhao, Z. and Tan, W. (2012A) Nucleic acid aptamers: an emerging frontier in cancer therapy. Chem. Commun. (Camb) 48, 10472-10480.
118. Zhu, Q., Shibata, T., Kabashima, T. and Kai, M. (2012B) Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-medi-ated specific delivery of siRNA. Eur. J. Med. Chem. 56, 396-399.